Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsia Dragon Regulatory News (DGN)

Share Price Information for Asia Dragon (DGN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 393.00
Bid: 391.00
Ask: 394.00
Change: 1.00 (0.26%)
Spread: 3.00 (0.767%)
Open: 396.00
High: 397.00
Low: 393.00
Prev. Close: 392.00
DGN Live PriceLast checked at -
Asia Dragon is an Investment Trust

The objective is long-term capital growth through investment in Asia, with the exception of Japan and Australasia. Investments are made primarily in stock markets in the region, principally in large companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Review Announcement

21 May 2024 07:00

RNS Number : 1821P
Asia Dragon Trust PLC
21 May 2024
 

21 May 2024

 

Asia Dragon Trust plc

Legal Entity Identifier (LEI): 549300W4KB0D75D1N730

 

Strategic Review

 

The Board of Asia Dragon Trust plc (the "Company") today announces a full strategic review of the future of the Company, including the ongoing investment management arrangements.

 

Background to the strategic review

 

In July 2023, the Company announced a proposed combination (the "Combination") with abrdn New Dawn Investment Trust plc to create an enlarged company with greater secondary market liquidity, lower management fees and lower ongoing charges. The Company amended its investment policy to allow for investment into Australasia to provide greater geographic flexibility. The Combination completed in November 2023.

 

The Board stated in the Company's prospectus relating to the Combination that it would continue to monitor performance, in particular in order to understand the drivers behind relative performance of the Company and actions being taken by the Company's investment manager, abrdn Fund Managers Limited, in the light of such performance. That included monitoring the discount at which the shares of the Company trade to its net asset value. In connection with this exercise, and further to the Company's announcement on 7 May 2024, the Board believes it is now appropriate to undertake a full strategic review of the future of the Company, including the ongoing investment management arrangements.

 

The Board has appointed Stanhope Consulting to assist in its strategic review. The Board will be interested to consider proposals from established fund management groups with experience of managing equity strategies similar to that currently pursued by the Company. Any such proposals will be considered alongside the current management arrangements. Interested parties are invited to contact Stanhope Consulting on the contact details below.

 

There is no certainty that any changes will result from the strategic review. The Board will make further announcements in due course.

 

Enquiries:

 

Asia Dragon Trust plc

James Will (Chairman)

 

Via FTI Consulting

Winterflood Investment Trusts

Neil Langford

 

+44 (0)20 3100 0000

Stanhope Consulting LLP

 

cfranklin@stanhopecapital.com

FTI Consulting

Ed Berry

Tom O'Brien

 

+44 (0)7703 330 199

+44 (0)7746 816 032

 

 

Important Information

 

This announcement contains information that is inside information for the purposes of the Market Abuse Regulation (EU) No 596/2014 as implemented in the UK. The person responsible for arranging for the release of this announcement on behalf of the Company is James Will, Chairman.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDUDBDDGSG
Date   Source Headline
13th Jun 20245:22 pmRNSTransaction in Own Shares
13th Jun 20244:28 pmRNSPortfolio disclosure
13th Jun 202412:57 pmRNSNet Asset Value(s)
13th Jun 202410:25 amRNSDirector Declarations
12th Jun 20245:27 pmRNSTransaction in Own Shares
12th Jun 202411:52 amRNSNet Asset Value(s)
11th Jun 20245:28 pmRNSTransaction in Own Shares
11th Jun 202412:39 pmRNSNet Asset Value(s)
10th Jun 20242:36 pmRNSGearing Disclosure
10th Jun 202412:55 pmRNSNet Asset Value(s)
7th Jun 202412:50 pmRNSNet Asset Value(s)
7th Jun 202411:13 amRNSQuarterly Disclosure
6th Jun 202412:22 pmRNSNet Asset Value(s)
6th Jun 202411:16 amRNSMonth End Net Asset Value(s)
5th Jun 20245:10 pmRNSTransaction in Own Shares
5th Jun 20241:13 pmRNSNet Asset Value(s)
4th Jun 202411:55 amRNSNet Asset Value(s)
3rd Jun 20242:04 pmRNSGearing Disclosures
3rd Jun 20249:51 amRNSTotal Voting Rights
31st May 202412:05 pmRNSNet Asset Value(s)
30th May 202411:41 amRNSNet Asset Value(s)
29th May 202411:40 amRNSNet Asset Value(s)
28th May 20242:51 pmRNSGearing disclosure
28th May 202411:42 amRNSNet Asset Value(s)
24th May 20241:10 pmRNSNet Asset Value(s)
23rd May 202412:27 pmRNSNet Asset Value(s)
22nd May 202412:37 pmRNSNet Asset Value(s)
21st May 20245:04 pmRNSTransaction in Own Shares
21st May 202412:15 pmRNSNet Asset Value(s)
21st May 20247:00 amRNSStrategic Review Announcement
20th May 20245:05 pmRNSTransaction in Own Shares
20th May 20241:03 pmRNSGearing disclosure
20th May 202412:14 pmRNSNet Asset Value(s)
17th May 20245:22 pmRNSTransaction in Own Shares
17th May 202412:27 pmRNSNet Asset Value(s)
16th May 20246:05 pmRNSPortfolio disclosure
16th May 20245:19 pmRNSTransaction in Own Shares
16th May 202412:21 pmRNSNet Asset Value(s)
15th May 202412:34 pmRNSNet Asset Value(s)
14th May 202411:48 amRNSNet Asset Value(s)
13th May 20242:37 pmRNSGearing disclosure
13th May 202412:23 pmRNSNet Asset Value(s)
10th May 202412:35 pmRNSNet Asset Value(s)
9th May 202412:15 pmRNSNet Asset Value(s)
9th May 20247:00 amRNSBoard Changes
8th May 20243:00 pmRNSDoc re. Half Yearly Report
8th May 202412:54 pmRNSNet Asset Value(s)
7th May 20245:27 pmRNSMonth End Net Asset Value(s)
7th May 202412:49 pmRNSGearing disclosure
7th May 202412:26 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.